Stock comparison
Jeena Sikho Lifecare Limited
JSLL.BO$72.12BHealthcare Market cap, Sector
Novartis AG
NVS$292.64BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
JSLL.BO 70 NVS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.BO7wins
0winsNVS
84B
C62
87A
C69
92A
D53
66C
F35
75B
D46
91A
C69
95A
C66
Side-by-side metrics
| Metric | JSLL.BO | NVS |
|---|---|---|
| Market cap | $72.12B | $292.64B Winner |
| P/E (TTM) | 33.2x | 21.4x Winner |
| EV/EBIT | 24.1x | 19.2x Winner |
| ROIC (TTM) | Winner: 39.15% | 14.89% |
| Gross margin | Winner: 88.58% | 75.13% |
| Net margin | Winner: 27.68% | 24.31% |
| Revenue CAGR 5y | Winner: 57.81% | 5.66% |
| EPS CAGR 5y | Winner: 86.67% | -9.29% |
| Debt / Equity | Winner: 0.3x | 1.2x |
| Dividend yield | - | 3.13% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.BO leads on
- EPS CAGR 5y86.67%vs -9.29%+111%
- Revenue CAGR 5y57.81%vs 5.66%+90%
- Debt / Equity0.3xvs 1.2x+78%
- ROIC (TTM)39.15%vs 14.89%+62%
NVS leads on
- Market cap$292.64Bvs $72.12B+75%
- P/E (TTM)21.4xvs 33.2x+36%
- EV/EBIT19.2xvs 24.1x+20%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.